Mannin Research
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
629 Eastern Ave Ste C300, Toronto, Ontar...Phone Number
(416) 775-9767Website
www.mannin.caRevenue
<$5 MillionIndustry
About Mannin Research
Mannin Research Org Chart
Is Mannin Research your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Mannin Research has new funding data
Check out if Mannin Research is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Mannin Research launches new products
Earning: See what the market has to say on Mannin Research recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Mannin Research
Click to see if Mannin Research had a recent Job posting/layoffs
Check if Mannin Research has recently received funding, and reach out quickly before it becomes old news!
Mannin Research, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Mannin Research
Find 3 more new buyers
Compare Similar Companies to Mannin Research
Compare insights from companies similar to Mannin Research, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Mannin Research is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Mannin Research is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Mannin Research.
Mannin Research Tech Stack
A closer look at the technologies used by Mannin Research
Mannin Research News & Media
Q BioMed Technology Partner Mannin Research Inc. Announced as Member of Canadian National COVID-19 Consortium
NEW YORK, Dec. 21, 2020 /PRNewswire/ -- Q BioMed, Inc. (OTCQB: QBIO) is pleased to announce that its technology partner Mannin Research Inc. (MRI), a private Canadian biotechnology company, is a member of the Canadian national COVID Cloud consortium. The platform will be used by MRI to...Q BioMed Partner Mannin Research Developing Potential Treatment for Patients Infected with Coronavirus and Other Infectious Diseases
NEW YORK, Feb. 4, 2020 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today that its research partner Mannin Research Inc. (Mannin) is developing new therapeutics to treat a variety of vascular diseases, including the new coronavirus which...Q BioMed Technology Partner Mannin Research Inc. Presents Data Showing Potential Treatment to Protect the Kidney in Acute Kidney Injury Using Mannin Tie2 Activator
NEW YORK, Nov. 26, 2019 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, is announcing today that its technology research partner Mannin Research Inc. (Mannin) presented positive data on a potential new treatment for acute kidney injury (AKI). The data was...Q BioMed Technology Partner Mannin Research Inc. Presents Data Showing Potential Treatment to Protect the Kidney in Acute Kidney Injury Using Mannin Tie2 Activator
Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, is announcing today that its technology research partner Mannin Research Inc. (Mannin) presented positive data on a potential new treatment for acute kidney injury (AKI). The data was presented at the American Society for Nephrology 2019 Annual Meeting held in Washington DC.
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Mannin Research
Mannin Research Inc. is an innovative biotechnology company dedicated to developing and commercializing new drugs for patients with ophthalmic diseases. The company focuses on creating novel therapeutics that target the Ang-Tie2 mechanism of action. Their first indication is glaucoma, where they aim to treat patients with first-in-class drugs. Mann... Read More